Charity Huang, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Roche/Genentech
    Date added:
    09/07/2023
    Date updated:
    09/07/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Pfizer
    Date added:
    09/07/2023
    Date updated:
    09/07/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Regeneron
    Date added:
    09/07/2023
    Date updated:
    09/07/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Amgen
    Date added:
    09/07/2023
    Date updated:
    09/07/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Eli Lilly
    Date added:
    09/07/2023
    Date updated:
    09/07/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Seagen
    Date added:
    09/07/2023
    Date updated:
    09/07/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Natera
    Date added:
    09/07/2023
    Date updated:
    09/07/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Theradex Oncology
    Date added:
    09/07/2023
    Date updated:
    09/07/2023
Return to 2023 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes